← Alle mensen

RM

Rui Ma

5 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Gevorderd NSCLC.

The New England journal of medicine · 1 januari 2026

Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as eerstelijns treatment of metastatic n...

The Lancet. Oncology · 2025-07

Durvalumab Versus Chemotherapy as First-line Behandeling for Metastatic NSCLC With Tumor PD-L1 Expression of 25% or H...

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025-03

Aumolertinib versus gefitinib als eerstelijns bij EGFR-gemuteerd NSCLC: AENEAS fase III

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 september 2022

Sintilimab plus pemetrexed-platina als eerstelijns bij NSCLC: ORIENT-11 fase III

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2020-10